Filing
Spy
Filing
Spy
Home
About
AKBA — Akebia Therapeutics Inc - FilingSpy
AKBA
Akebia Therapeutics Inc
Biopharmaceutical company
CUSIP: 00972D105
Healthcare
US
2 holders
Ownership
Activity
Fundamentals
2019 Q3
7 of 11 quarters
Total Value
$118.10M
Total Shares
30.13M
Net Share Change
0
Activity
No changes
Investor
Value
Shares
Weight
Change
Baupost Group LLC
$95.93M
24.47M
1.1%
Unchanged
Baupost Group LLC
$95.93M
24.47M shares
Unchanged
Abrams Capital Management
$22.17M
5.66M
0.6%
Unchanged
Abrams Capital Management
$22.17M
5.66M shares
Unchanged